| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.132 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
1.132 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
STAT3 |
|
1.132 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.132 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
1.132 |
Evidence |
|
| IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
| TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
| CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
1.132 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
1.132 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.132 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
| KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
JAK1 |
|
1.132 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|